206 related articles for article (PubMed ID: 24496335)
21. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Aslanabadi N; Shirzadi HR; Asghari-Soufi H; Dousti S; Ghaffari S; Sohrabi B; Mashayekhi SO; Hamishehkar H; Entezari-Maleki T
Eur J Clin Pharmacol; 2015 Feb; 71(2):143-9. PubMed ID: 25475357
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
[TBL] [Abstract][Full Text] [Related]
23. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
24. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
25. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
[TBL] [Abstract][Full Text] [Related]
26. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?
Iliodromitis EK; Kyrzopoulos S; Paraskevaidis IA; Kolocassides KG; Adamopoulos S; Karavolias G; Kremastinos DT
Heart; 2006 Dec; 92(12):1821-6. PubMed ID: 16855045
[TBL] [Abstract][Full Text] [Related]
27. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
28. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
29. The effect of dalteparin versus unfractionated heparin on the levels of troponin I and creatine kinase isoenzyme MB in elective percutaneous coronary intervention: a multicenter study.
Zhang G; Cui W; Li Y; Gao X; Wei Q; Cao X; Xiao W; Jiang P; Lyu X; Liu F; Gu G; Liu J
Coron Artery Dis; 2014 Sep; 25(6):510-5. PubMed ID: 24859356
[TBL] [Abstract][Full Text] [Related]
30. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
31. Role of serum myeloperoxidase, CPK, CK-MB, and cTnI tests in early diagnosis of myocardial ischemia during ERCP.
Yıldız K; Ince AT; Sarbay Kemik A; Sert S; Isen HC; Tozlu M; Baysal B; Akyüz U; Kocaman O; Danalıoğlu A
Turk J Gastroenterol; 2014 Jun; 25(3):291-7. PubMed ID: 25141318
[TBL] [Abstract][Full Text] [Related]
32. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
[TBL] [Abstract][Full Text] [Related]
33. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
Med Sci Monit; 2000; 6(4):708-12. PubMed ID: 11208396
[TBL] [Abstract][Full Text] [Related]
34. Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
Kirali K; Mansuroğlu D; Kayalar N; Güzelmeriç F; Alp M; Yakut C
Heart Surg Forum; 2003; 6(3):143-8. PubMed ID: 12821428
[TBL] [Abstract][Full Text] [Related]
35. Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).
Connolly M; Shand J; Kinnin M; Menown I; Kurth MJ; Lamont J; Mc Eneaney D
QJM; 2018 Jan; 111(1):33-38. PubMed ID: 29040663
[TBL] [Abstract][Full Text] [Related]
36. Cardiac troponin T and creatine kinase MB isoenzyme as biochemical markers of ischemia after heart preservation and transplantation.
Carrier M; Solymoss BC; Cartier R; Leclerc Y; Pelletier LC
J Heart Lung Transplant; 1994; 13(4):696-700. PubMed ID: 7947887
[TBL] [Abstract][Full Text] [Related]
37. Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test.
Dobric M; Giga V; Beleslin B; Ignjatovic S; Paunovic I; Stepanovic J; Djordjevic-Dikic A; Kostic J; Nedeljkovic I; Nedeljkovic M; Tesic M; Dajak M; Ostojic M
Clin Chem Lab Med; 2013 Oct; 51(10):2029-35. PubMed ID: 23729628
[TBL] [Abstract][Full Text] [Related]
38. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
Aslanabadi N; Safaie N; Asgharzadeh Y; Houshmand F; Ghaffari S; Garjani A; Dousti S; Hamishehkar H; Entezari-Maleki T
Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
[TBL] [Abstract][Full Text] [Related]
39. Troponin I and Creatine Kinase MB do not provide comparable information after PCI.
Gustavsson CG; Nilson M
Scand Cardiovasc J; 2011 Feb; 45(1):21-6. PubMed ID: 21114454
[TBL] [Abstract][Full Text] [Related]
40. The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention.
Ke-Wu D; Xu-Bo S; Ying-Xin Z; Shi-Wei Y; Yu-Jie Z; Dong-Mei S; Yu-Yang L; De-An J; Zhe F; Zhi-Ming Z; Hai-Long G; Zhen-Xian Y; Chang-Sheng M
Angiology; 2015 Feb; 66(2):163-8. PubMed ID: 24368725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
